BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5771871)

  • 1. [Calcium phosphate as adjuvant in vaccinations in man].
    Relyveld EH; Martin R; Raynaud M; Damas JP; Thérond C; Hénocq E; Romain F; Turpin A; Céolin G; Chevé J; Digeon M; Cheyroux M
    Ann Inst Pasteur (Paris); 1969 Mar; 116(3):300-26. PubMed ID: 5771871
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccination with calcium phosphate adsorbed antigens].
    Relyveld EH; Martin R; Raynaud M; Hénocq E; Damas JP
    Prog Immunobiol Stand; 1970; 4():540-7. PubMed ID: 5482198
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.
    Gabutti G
    J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccination statistics for the year 1964 (D.T. and associated D.T. vaccines: D.T.T.A.B.: D.T. polio; D.T.C.; D.T.C. polio)].
    Chassagne P; Devaux JP
    Bull Inst Natl Sante Rech Med; 1966; 21(4):663-71. PubMed ID: 5974691
    [No Abstract]   [Full Text] [Related]  

  • 5. [Norms o vaccination in the republic of Ecuador].
    Aroca Campodónico F; Baldeón Barros WG
    Rev Ecuat Hig Med Trop; 1969; 26(2):141-63. PubMed ID: 5400615
    [No Abstract]   [Full Text] [Related]  

  • 6. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine.
    Black S; Greenberg DP
    Expert Rev Vaccines; 2005 Dec; 4(6):793-805. PubMed ID: 16372875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New data on the possibilities of immunizing infants during their first years].
    Mande R; Fillastre C; Ajjan N; Orssaud E
    Arch Fr Pediatr; 1969 Feb; 26(2):155-77. PubMed ID: 5375874
    [No Abstract]   [Full Text] [Related]  

  • 10. Statement on the recommended use of pentavalent and hexavalent vaccines. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Feb; 33(ACS-1):1-14. PubMed ID: 17294559
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute encephalopathy after polyvalent vaccination (diphtheria, tetanus, whooping cough, poliomyelitis)].
    Duc H; Jobey
    Pediatrie; 1967; 22(3):356-7. PubMed ID: 5607354
    [No Abstract]   [Full Text] [Related]  

  • 12. [The evolution of the specific and active prophylaxis of infectious diseases in humans (diphtheria, whooping cough, tetanus, scarlet fever, tuberculosis, poliomyelitis)].
    HAAS R
    Dtsch Med Wochenschr; 1954 Mar; 79(11):428-32. PubMed ID: 13161501
    [No Abstract]   [Full Text] [Related]  

  • 13. [Considerations on the advisability of beginning the first immunization against diphtheria, tetanus, whooping cough and poliomyelitis in infants at the age of 3 months].
    MURANO G
    Nourrisson; 1960; 48():187-90. PubMed ID: 13726888
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
    Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunization of infants with a triple adsorbed vaccine against diphtheria, tetanus and whooping cough].
    GIRARD O; NICOL L; CHEVE J; AMOUREUX G; ZOURBAS J; CARAES Y
    Ann Inst Pasteur (Paris); 1959 Apr; 96(4):491-5. PubMed ID: 13650292
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunizing strength and tolerance by the human organism of vaccines adsorbed on calcium phosphate].
    Martin R; Relyveld EH; Raynaud M; Damas JP; Henocq E
    Presse Med (1893); 1969 Feb; 77(10):341-4. PubMed ID: 5796019
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diphtheria, whooping cough & tetanus vaccination in the child].
    LOIZAGA CA
    Dia Med; 1958 Feb; 30(7):180-1. PubMed ID: 13537775
    [No Abstract]   [Full Text] [Related]  

  • 18. [On antidiphtheric, antitetanic and antipoliomyelitic vaccinations in France in the years 1965-1966].
    Martin-Bouyer G; Devaux JP; Veiga-Pires MH
    Bull Inst Natl Sante Rech Med; 1969; 24(2):277-89. PubMed ID: 5401850
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relation of type of vaccine & inoculation method to vaccination reactions after immunization against whooping cough diphtheria & tetauns].
    TASMAN A
    Ned Tijdschr Geneeskd; 1959 May; 103(20):1049-57. PubMed ID: 13666915
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reactions and complications caused by preventive vaccinations].
    Del Campo A
    G Mal Infett Parassit; 1970 Apr; 22(4):249-63. PubMed ID: 5515864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.